Global Non-animal Capsule Market Growth 2025-2031
The global Non-animal Capsule market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S... もっと見る
英語原文をAIを使って翻訳しています。
SummaryThe global Non-animal Capsule market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Non-animal Capsule is made by pullulan or hypromellose or starch. Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 178%. LP Information, Inc. (LPI) ' newest research report, the “Non-animal Capsule Industry Forecast” looks at past sales and reviews total world Non-animal Capsule sales in 2024, providing a comprehensive analysis by region and market sector of projected Non-animal Capsule sales for 2025 through 2031. With Non-animal Capsule sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-animal Capsule industry. This Insight Report provides a comprehensive analysis of the global Non-animal Capsule landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-animal Capsule portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-animal Capsule market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-animal Capsule and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-animal Capsule. This report presents a comprehensive overview, market shares, and growth opportunities of Non-animal Capsule market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: Plant Polysaccharides Starch HPMC Others Segmentation by Application: Pharmaceutical Health Supplements Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration. Lonza (Capsugel) ACG Associated Capsules Qualicaps Shanxi GS Capsule CapsCanada Suheung Capsule Qingdao Capsule Lefan Capsule Sunil Healthcare Catalent Er-kang Bahrain Pharma Aenova Procaps Laboratorios SIRIO Eurocaps Best Formulations Captek Robinson Pharma Key Questions Addressed in this Report What is the 10-year outlook for the global Non-animal Capsule market? What factors are driving Non-animal Capsule market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Non-animal Capsule market opportunities vary by end market size? How does Non-animal Capsule break out by Type, by Application? Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Non-animal Capsule Annual Sales 2020-2031 2.1.2 World Current & Future Analysis for Non-animal Capsule by Geographic Region, 2020, 2024 & 2031 2.1.3 World Current & Future Analysis for Non-animal Capsule by Country/Region, 2020, 2024 & 2031 2.2 Non-animal Capsule Segment by Type 2.2.1 Plant Polysaccharides 2.2.2 Starch 2.2.3 HPMC 2.2.4 Others 2.3 Non-animal Capsule Sales by Type 2.3.1 Global Non-animal Capsule Sales Market Share by Type (2020-2025) 2.3.2 Global Non-animal Capsule Revenue and Market Share by Type (2020-2025) 2.3.3 Global Non-animal Capsule Sale Price by Type (2020-2025) 2.4 Non-animal Capsule Segment by Application 2.4.1 Pharmaceutical 2.4.2 Health Supplements 2.4.3 Others 2.5 Non-animal Capsule Sales by Application 2.5.1 Global Non-animal Capsule Sale Market Share by Application (2020-2025) 2.5.2 Global Non-animal Capsule Revenue and Market Share by Application (2020-2025) 2.5.3 Global Non-animal Capsule Sale Price by Application (2020-2025) 3 Global by Company 3.1 Global Non-animal Capsule Breakdown Data by Company 3.1.1 Global Non-animal Capsule Annual Sales by Company (2020-2025) 3.1.2 Global Non-animal Capsule Sales Market Share by Company (2020-2025) 3.2 Global Non-animal Capsule Annual Revenue by Company (2020-2025) 3.2.1 Global Non-animal Capsule Revenue by Company (2020-2025) 3.2.2 Global Non-animal Capsule Revenue Market Share by Company (2020-2025) 3.3 Global Non-animal Capsule Sale Price by Company 3.4 Key Manufacturers Non-animal Capsule Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Non-animal Capsule Product Location Distribution 3.4.2 Players Non-animal Capsule Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Non-animal Capsule by Geographic Region 4.1 World Historic Non-animal Capsule Market Size by Geographic Region (2020-2025) 4.1.1 Global Non-animal Capsule Annual Sales by Geographic Region (2020-2025) 4.1.2 Global Non-animal Capsule Annual Revenue by Geographic Region (2020-2025) 4.2 World Historic Non-animal Capsule Market Size by Country/Region (2020-2025) 4.2.1 Global Non-animal Capsule Annual Sales by Country/Region (2020-2025) 4.2.2 Global Non-animal Capsule Annual Revenue by Country/Region (2020-2025) 4.3 Americas Non-animal Capsule Sales Growth 4.4 APAC Non-animal Capsule Sales Growth 4.5 Europe Non-animal Capsule Sales Growth 4.6 Middle East & Africa Non-animal Capsule Sales Growth 5 Americas 5.1 Americas Non-animal Capsule Sales by Country 5.1.1 Americas Non-animal Capsule Sales by Country (2020-2025) 5.1.2 Americas Non-animal Capsule Revenue by Country (2020-2025) 5.2 Americas Non-animal Capsule Sales by Type (2020-2025) 5.3 Americas Non-animal Capsule Sales by Application (2020-2025) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Non-animal Capsule Sales by Region 6.1.1 APAC Non-animal Capsule Sales by Region (2020-2025) 6.1.2 APAC Non-animal Capsule Revenue by Region (2020-2025) 6.2 APAC Non-animal Capsule Sales by Type (2020-2025) 6.3 APAC Non-animal Capsule Sales by Application (2020-2025) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Non-animal Capsule by Country 7.1.1 Europe Non-animal Capsule Sales by Country (2020-2025) 7.1.2 Europe Non-animal Capsule Revenue by Country (2020-2025) 7.2 Europe Non-animal Capsule Sales by Type (2020-2025) 7.3 Europe Non-animal Capsule Sales by Application (2020-2025) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Non-animal Capsule by Country 8.1.1 Middle East & Africa Non-animal Capsule Sales by Country (2020-2025) 8.1.2 Middle East & Africa Non-animal Capsule Revenue by Country (2020-2025) 8.2 Middle East & Africa Non-animal Capsule Sales by Type (2020-2025) 8.3 Middle East & Africa Non-animal Capsule Sales by Application (2020-2025) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Non-animal Capsule 10.3 Manufacturing Process Analysis of Non-animal Capsule 10.4 Industry Chain Structure of Non-animal Capsule 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Non-animal Capsule Distributors 11.3 Non-animal Capsule Customer 12 World Forecast Review for Non-animal Capsule by Geographic Region 12.1 Global Non-animal Capsule Market Size Forecast by Region 12.1.1 Global Non-animal Capsule Forecast by Region (2026-2031) 12.1.2 Global Non-animal Capsule Annual Revenue Forecast by Region (2026-2031) 12.2 Americas Forecast by Country (2026-2031) 12.3 APAC Forecast by Region (2026-2031) 12.4 Europe Forecast by Country (2026-2031) 12.5 Middle East & Africa Forecast by Country (2026-2031) 12.6 Global Non-animal Capsule Forecast by Type (2026-2031) 12.7 Global Non-animal Capsule Forecast by Application (2026-2031) 13 Key Players Analysis 13.1 Lonza (Capsugel) 13.1.1 Lonza (Capsugel) Company Information 13.1.2 Lonza (Capsugel) Non-animal Capsule Product Portfolios and Specifications 13.1.3 Lonza (Capsugel) Non-animal Capsule Sales, Revenue, Price and Gross Margin (2020-2025) 13.1.4 Lonza (Capsugel) Main Business Overview 13.1.5 Lonza (Capsugel) Latest Developments 13.2 ACG Associated Capsules 13.2.1 ACG Associated Capsules Company Information 13.2.2 ACG Associated Capsules Non-animal Capsule Product Portfolios and Specifications 13.2.3 ACG Associated Capsules Non-animal Capsule Sales, Revenue, Price and Gross Margin (2020-2025) 13.2.4 ACG Associated Capsules Main Business Overview 13.2.5 ACG Associated Capsules Latest Developments 13.3 Qualicaps 13.3.1 Qualicaps Company Information 13.3.2 Qualicaps Non-animal Capsule Product Portfolios and Specifications 13.3.3 Qualicaps Non-animal Capsule Sales, Revenue, Price and Gross Margin (2020-2025) 13.3.4 Qualicaps Main Business Overview 13.3.5 Qualicaps Latest Developments 13.4 Shanxi GS Capsule 13.4.1 Shanxi GS Capsule Company Information 13.4.2 Shanxi GS Capsule Non-animal Capsule Product Portfolios and Specifications 13.4.3 Shanxi GS Capsule Non-animal Capsule Sales, Revenue, Price and Gross Margin (2020-2025) 13.4.4 Shanxi GS Capsule Main Business Overview 13.4.5 Shanxi GS Capsule Latest Developments 13.5 CapsCanada 13.5.1 CapsCanada Company Information 13.5.2 CapsCanada Non-animal Capsule Product Portfolios and Specifications 13.5.3 CapsCanada Non-animal Capsule Sales, Revenue, Price and Gross Margin (2020-2025) 13.5.4 CapsCanada Main Business Overview 13.5.5 CapsCanada Latest Developments 13.6 Suheung Capsule 13.6.1 Suheung Capsule Company Information 13.6.2 Suheung Capsule Non-animal Capsule Product Portfolios and Specifications 13.6.3 Suheung Capsule Non-animal Capsule Sales, Revenue, Price and Gross Margin (2020-2025) 13.6.4 Suheung Capsule Main Business Overview 13.6.5 Suheung Capsule Latest Developments 13.7 Qingdao Capsule 13.7.1 Qingdao Capsule Company Information 13.7.2 Qingdao Capsule Non-animal Capsule Product Portfolios and Specifications 13.7.3 Qingdao Capsule Non-animal Capsule Sales, Revenue, Price and Gross Margin (2020-2025) 13.7.4 Qingdao Capsule Main Business Overview 13.7.5 Qingdao Capsule Latest Developments 13.8 Lefan Capsule 13.8.1 Lefan Capsule Company Information 13.8.2 Lefan Capsule Non-animal Capsule Product Portfolios and Specifications 13.8.3 Lefan Capsule Non-animal Capsule Sales, Revenue, Price and Gross Margin (2020-2025) 13.8.4 Lefan Capsule Main Business Overview 13.8.5 Lefan Capsule Latest Developments 13.9 Sunil Healthcare 13.9.1 Sunil Healthcare Company Information 13.9.2 Sunil Healthcare Non-animal Capsule Product Portfolios and Specifications 13.9.3 Sunil Healthcare Non-animal Capsule Sales, Revenue, Price and Gross Margin (2020-2025) 13.9.4 Sunil Healthcare Main Business Overview 13.9.5 Sunil Healthcare Latest Developments 13.10 Catalent 13.10.1 Catalent Company Information 13.10.2 Catalent Non-animal Capsule Product Portfolios and Specifications 13.10.3 Catalent Non-animal Capsule Sales, Revenue, Price and Gross Margin (2020-2025) 13.10.4 Catalent Main Business Overview 13.10.5 Catalent Latest Developments 13.11 Er-kang 13.11.1 Er-kang Company Information 13.11.2 Er-kang Non-animal Capsule Product Portfolios and Specifications 13.11.3 Er-kang Non-animal Capsule Sales, Revenue, Price and Gross Margin (2020-2025) 13.11.4 Er-kang Main Business Overview 13.11.5 Er-kang Latest Developments 13.12 Bahrain Pharma 13.12.1 Bahrain Pharma Company Information 13.12.2 Bahrain Pharma Non-animal Capsule Product Portfolios and Specifications 13.12.3 Bahrain Pharma Non-animal Capsule Sales, Revenue, Price and Gross Margin (2020-2025) 13.12.4 Bahrain Pharma Main Business Overview 13.12.5 Bahrain Pharma Latest Developments 13.13 Aenova 13.13.1 Aenova Company Information 13.13.2 Aenova Non-animal Capsule Product Portfolios and Specifications 13.13.3 Aenova Non-animal Capsule Sales, Revenue, Price and Gross Margin (2020-2025) 13.13.4 Aenova Main Business Overview 13.13.5 Aenova Latest Developments 13.14 Procaps Laboratorios 13.14.1 Procaps Laboratorios Company Information 13.14.2 Procaps Laboratorios Non-animal Capsule Product Portfolios and Specifications 13.14.3 Procaps Laboratorios Non-animal Capsule Sales, Revenue, Price and Gross Margin (2020-2025) 13.14.4 Procaps Laboratorios Main Business Overview 13.14.5 Procaps Laboratorios Latest Developments 13.15 SIRIO 13.15.1 SIRIO Company Information 13.15.2 SIRIO Non-animal Capsule Product Portfolios and Specifications 13.15.3 SIRIO Non-animal Capsule Sales, Revenue, Price and Gross Margin (2020-2025) 13.15.4 SIRIO Main Business Overview 13.15.5 SIRIO Latest Developments 13.16 Eurocaps 13.16.1 Eurocaps Company Information 13.16.2 Eurocaps Non-animal Capsule Product Portfolios and Specifications 13.16.3 Eurocaps Non-animal Capsule Sales, Revenue, Price and Gross Margin (2020-2025) 13.16.4 Eurocaps Main Business Overview 13.16.5 Eurocaps Latest Developments 13.17 Best Formulations 13.17.1 Best Formulations Company Information 13.17.2 Best Formulations Non-animal Capsule Product Portfolios and Specifications 13.17.3 Best Formulations Non-animal Capsule Sales, Revenue, Price and Gross Margin (2020-2025) 13.17.4 Best Formulations Main Business Overview 13.17.5 Best Formulations Latest Developments 13.18 Captek 13.18.1 Captek Company Information 13.18.2 Captek Non-animal Capsule Product Portfolios and Specifications 13.18.3 Captek Non-animal Capsule Sales, Revenue, Price and Gross Margin (2020-2025) 13.18.4 Captek Main Business Overview 13.18.5 Captek Latest Developments 13.19 Robinson Pharma 13.19.1 Robinson Pharma Company Information 13.19.2 Robinson Pharma Non-animal Capsule Product Portfolios and Specifications 13.19.3 Robinson Pharma Non-animal Capsule Sales, Revenue, Price and Gross Margin (2020-2025) 13.19.4 Robinson Pharma Main Business Overview 13.19.5 Robinson Pharma Latest Developments 14 Research Findings and Conclusion List of Tables/GraphsList of TablesTable 1. Non-animal Capsule Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions) Table 2. Non-animal Capsule Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions) Table 3. Major Players of Plant Polysaccharides Table 4. Major Players of Starch Table 5. Major Players of HPMC Table 6. Major Players of Others Table 7. Global Non-animal Capsule Sales by Type (2020-2025) & (K Units) Table 8. Global Non-animal Capsule Sales Market Share by Type (2020-2025) Table 9. Global Non-animal Capsule Revenue by Type (2020-2025) & ($ million) Table 10. Global Non-animal Capsule Revenue Market Share by Type (2020-2025) Table 11. Global Non-animal Capsule Sale Price by Type (2020-2025) & (USD/Unit) Table 12. Global Non-animal Capsule Sale by Application (2020-2025) & (K Units) Table 13. Global Non-animal Capsule Sale Market Share by Application (2020-2025) Table 14. Global Non-animal Capsule Revenue by Application (2020-2025) & ($ million) Table 15. Global Non-animal Capsule Revenue Market Share by Application (2020-2025) Table 16. Global Non-animal Capsule Sale Price by Application (2020-2025) & (USD/Unit) Table 17. Global Non-animal Capsule Sales by Company (2020-2025) & (K Units) Table 18. Global Non-animal Capsule Sales Market Share by Company (2020-2025) Table 19. Global Non-animal Capsule Revenue by Company (2020-2025) & ($ millions) Table 20. Global Non-animal Capsule Revenue Market Share by Company (2020-2025) Table 21. Global Non-animal Capsule Sale Price by Company (2020-2025) & (USD/Unit) Table 22. Key Manufacturers Non-animal Capsule Producing Area Distribution and Sales Area Table 23. Players Non-animal Capsule Products Offered Table 24. Non-animal Capsule Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) Table 25. New Products and Potential Entrants Table 26. Market M&A Activity & Strategy Table 27. Global Non-animal Capsule Sales by Geographic Region (2020-2025) & (K Units) Table 28. Global Non-animal Capsule Sales Market Share Geographic Region (2020-2025) Table 29. Global Non-animal Capsule Revenue by Geographic Region (2020-2025) & ($ millions) Table 30. Global Non-animal Capsule Revenue Market Share by Geographic Region (2020-2025) Table 31. Global Non-animal Capsule Sales by Country/Region (2020-2025) & (K Units) Table 32. Global Non-animal Capsule Sales Market Share by Country/Region (2020-2025) Table 33. Global Non-animal Capsule Revenue by Country/Region (2020-2025) & ($ millions) Table 34. Global Non-animal Capsule Revenue Market Share by Country/Region (2020-2025) Table 35. Americas Non-animal Capsule Sales by Country (2020-2025) & (K Units) Table 36. Americas Non-animal Capsule Sales Market Share by Country (2020-2025) Table 37. Americas Non-animal Capsule Revenue by Country (2020-2025) & ($ millions) Table 38. Americas Non-animal Capsule Sales by Type (2020-2025) & (K Units) Table 39. Americas Non-animal Capsule Sales by Application (2020-2025) & (K Units) Table 40. APAC Non-animal Capsule Sales by Region (2020-2025) & (K Units) Table 41. APAC Non-animal Capsule Sales Market Share by Region (2020-2025) Table 42. APAC Non-animal Capsule Revenue by Region (2020-2025) & ($ millions) Table 43. APAC Non-animal Capsule Sales by Type (2020-2025) & (K Units) Table 44. APAC Non-animal Capsule Sales by Application (2020-2025) & (K Units) Table 45. Europe Non-animal Capsule Sales by Country (2020-2025) & (K Units) Table 46. Europe Non-animal Capsule Revenue by Country (2020-2025) & ($ millions) Table 47. Europe Non-animal Capsule Sales by Type (2020-2025) & (K Units) Table 48. Europe Non-animal Capsule Sales by Application (2020-2025) & (K Units) Table 49. Middle East & Africa Non-animal Capsule Sales by Country (2020-2025) & (K Units) Table 50. Middle East & Africa Non-animal Capsule Revenue Market Share by Country (2020-2025) Table 51. Middle East & Africa Non-animal Capsule Sales by Type (2020-2025) & (K Units) Table 52. Middle East & Africa Non-animal Capsule Sales by Application (2020-2025) & (K Units) Table 53. Key Market Drivers & Growth Opportunities of Non-animal Capsule Table 54. Key Market Challenges & Risks of Non-animal Capsule Table 55. Key Industry Trends of Non-animal Capsule Table 56. Non-animal Capsule Raw Material Table 57. Key Suppliers of Raw Materials Table 58. Non-animal Capsule Distributors List Table 59. Non-animal Capsule Customer List Table 60. Global Non-animal Capsule Sales Forecast by Region (2026-2031) & (K Units) Table 61. Global Non-animal Capsule Revenue Forecast by Region (2026-2031) & ($ millions) Table 62. Americas Non-animal Capsule Sales Forecast by Country (2026-2031) & (K Units) Table 63. Americas Non-animal Capsule Annual Revenue Forecast by Country (2026-2031) & ($ millions) Table 64. APAC Non-animal Capsule Sales Forecast by Region (2026-2031) & (K Units) Table 65. APAC Non-animal Capsule Annual Revenue Forecast by Region (2026-2031) & ($ millions) Table 66. Europe Non-animal Capsule Sales Forecast by Country (2026-2031) & (K Units) Table 67. Europe Non-animal Capsule Revenue Forecast by Country (2026-2031) & ($ millions) Table 68. Middle East & Africa Non-animal Capsule Sales Forecast by Country (2026-2031) & (K Units) Table 69. Middle East & Africa Non-animal Capsule Revenue Forecast by Country (2026-2031) & ($ millions) Table 70. Global Non-animal Capsule Sales Forecast by Type (2026-2031) & (K Units) Table 71. Global Non-animal Capsule Revenue Forecast by Type (2026-2031) & ($ millions) Table 72. Global Non-animal Capsule Sales Forecast by Application (2026-2031) & (K Units) Table 73. Global Non-animal Capsule Revenue Forecast by Application (2026-2031) & ($ millions) Table 74. Lonza (Capsugel) Basic Information, Non-animal Capsule Manufacturing Base, Sales Area and Its Competitors Table 75. Lonza (Capsugel) Non-animal Capsule Product Portfolios and Specifications Table 76. Lonza (Capsugel) Non-animal Capsule Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025) Table 77. Lonza (Capsugel) Main Business Table 78. Lonza (Capsugel) Latest Developments Table 79. ACG Associated Capsules Basic Information, Non-animal Capsule Manufacturing Base, Sales Area and Its Competitors Table 80. ACG Associated Capsules Non-animal Capsule Product Portfolios and Specifications Table 81. ACG Associated Capsules Non-animal Capsule Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025) Table 82. ACG Associated Capsules Main Business Table 83. ACG Associated Capsules Latest Developments Table 84. Qualicaps Basic Information, Non-animal Capsule Manufacturing Base, Sales Area and Its Competitors Table 85. Qualicaps Non-animal Capsule Product Portfolios and Specifications Table 86. Qualicaps Non-animal Capsule Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025) Table 87. Qualicaps Main Business Table 88. Qualicaps Latest Developments Table 89. Shanxi GS Capsule Basic Information, Non-animal Capsule Manufacturing Base, Sales Area and Its Competitors Table 90. Shanxi GS Capsule Non-animal Capsule Product Portfolios and Specifications Table 91. Shanxi GS Capsule Non-animal Capsule Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025) Table 92. Shanxi GS Capsule Main Business Table 93. Shanxi GS Capsule Latest Developments Table 94. CapsCanada Basic Information, Non-animal Capsule Manufacturing Base, Sales Area and Its Competitors Table 95. CapsCanada Non-animal Capsule Product Portfolios and Specifications Table 96. CapsCanada Non-animal Capsule Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025) Table 97. CapsCanada Main Business Table 98. CapsCanada Latest Developments Table 99. Suheung Capsule Basic Information, Non-animal Capsule Manufacturing Base, Sales Area and Its Competitors Table 100. Suheung Capsule Non-animal Capsule Product Portfolios and Specifications Table 101. Suheung Capsule Non-animal Capsule Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025) Table 102. Suheung Capsule Main Business Table 103. Suheung Capsule Latest Developments Table 104. Qingdao Capsule Basic Information, Non-animal Capsule Manufacturing Base, Sales Area and Its Competitors Table 105. Qingdao Capsule Non-animal Capsule Product Portfolios and Specifications Table 106. Qingdao Capsule Non-animal Capsule Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025) Table 107. Qingdao Capsule Main Business Table 108. Qingdao Capsule Latest Developments Table 109. Lefan Capsule Basic Information, Non-animal Capsule Manufacturing Base, Sales Area and Its Competitors Table 110. Lefan Capsule Non-animal Capsule Product Portfolios and Specifications Table 111. Lefan Capsule Non-animal Capsule Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025) Table 112. Lefan Capsule Main Business Table 113. Lefan Capsule Latest Developments Table 114. Sunil Healthcare Basic Information, Non-animal Capsule Manufacturing Base, Sales Area and Its Competitors Table 115. Sunil Healthcare Non-animal Capsule Product Portfolios and Specifications Table 116. Sunil Healthcare Non-animal Capsule Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025) Table 117. Sunil Healthcare Main Business Table 118. Sunil Healthcare Latest Developments Table 119. Catalent Basic Information, Non-animal Capsule Manufacturing Base, Sales Area and Its Competitors Table 120. Catalent Non-animal Capsule Product Portfolios and Specifications Table 121. Catalent Non-animal Capsule Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025) Table 122. Catalent Main Business Table 123. Catalent Latest Developments Table 124. Er-kang Basic Information, Non-animal Capsule Manufacturing Base, Sales Area and Its Competitors Table 125. Er-kang Non-animal Capsule Product Portfolios and Specifications Table 126. Er-kang Non-animal Capsule Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025) Table 127. Er-kang Main Business Table 128. Er-kang Latest Developments Table 129. Bahrain Pharma Basic Information, Non-animal Capsule Manufacturing Base, Sales Area and Its Competitors Table 130. Bahrain Pharma Non-animal Capsule Product Portfolios and Specifications Table 131. Bahrain Pharma Non-animal Capsule Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025) Table 132. Bahrain Pharma Main Business Table 133. Bahrain Pharma Latest Developments Table 134. Aenova Basic Information, Non-animal Capsule Manufacturing Base, Sales Area and Its Competitors Table 135. Aenova Non-animal Capsule Product Portfolios and Specifications Table 136. Aenova Non-animal Capsule Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025) Table 137. Aenova Main Business Table 138. Aenova Latest Developments Table 139. Procaps Laboratorios Basic Information, Non-animal Capsule Manufacturing Base, Sales Area and Its Competitors Table 140. Procaps Laboratorios Non-animal Capsule Product Portfolios and Specifications Table 141. Procaps Laboratorios Non-animal Capsule Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025) Table 142. Procaps Laboratorios Main Business Table 143. Procaps Laboratorios Latest Developments Table 144. SIRIO Basic Information, Non-animal Capsule Manufacturing Base, Sales Area and Its Competitors Table 145. SIRIO Non-animal Capsule Product Portfolios and Specifications Table 146. SIRIO Non-animal Capsule Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025) Table 147. SIRIO Main Business Table 148. SIRIO Latest Developments Table 149. Eurocaps Basic Information, Non-animal Capsule Manufacturing Base, Sales Area and Its Competitors Table 150. Eurocaps Non-animal Capsule Product Portfolios and Specifications Table 151. Eurocaps Non-animal Capsule Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025) Table 152. Eurocaps Main Business Table 153. Eurocaps Latest Developments Table 154. Best Formulations Basic Information, Non-animal Capsule Manufacturing Base, Sales Area and Its Competitors Table 155. Best Formulations Non-animal Capsule Product Portfolios and Specifications Table 156. Best Formulations Non-animal Capsule Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025) Table 157. Best Formulations Main Business Table 158. Best Formulations Latest Developments Table 159. Captek Basic Information, Non-animal Capsule Manufacturing Base, Sales Area and Its Competitors Table 160. Captek Non-animal Capsule Product Portfolios and Specifications Table 161. Captek Non-animal Capsule Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025) Table 162. Captek Main Business Table 163. Captek Latest Developments Table 164. Robinson Pharma Basic Information, Non-animal Capsule Manufacturing Base, Sales Area and Its Competitors Table 165. Robinson Pharma Non-animal Capsule Product Portfolios and Specifications Table 166. Robinson Pharma Non-animal Capsule Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025) Table 167. Robinson Pharma Main Business Table 168. Robinson Pharma Latest Developments List of Figures Figure 1. Picture of Non-animal Capsule Figure 2. Non-animal Capsule Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Non-animal Capsule Sales Growth Rate 2020-2031 (K Units) Figure 7. Global Non-animal Capsule Revenue Growth Rate 2020-2031 ($ millions) Figure 8. Non-animal Capsule Sales by Geographic Region (2020, 2024 & 2031) & ($ millions) Figure 9. Non-animal Capsule Sales Market Share by Country/Region (2024) Figure 10. Non-animal Capsule Sales Market Share by Country/Region (2020, 2024 & 2031) Figure 11. Product Picture of Plant Polysaccharides Figure 12. Product Picture of Starch Figure 13. Product Picture of HPMC Figure 14. Product Picture of Others Figure 15. Global Non-animal Capsule Sales Market Share by Type in 2025 Figure 16. Global Non-animal Capsule Revenue Market Share by Type (2020-2025) Figure 17. Non-animal Capsule Consumed in Pharmaceutical Figure 18. Global Non-animal Capsule Market: Pharmaceutical (2020-2025) & (K Units) Figure 19. Non-animal Capsule Consumed in Health Supplements Figure 20. Global Non-animal Capsule Market: Health Supplements (2020-2025) & (K Units) Figure 21. Non-animal Capsule Consumed in Others Figure 22. Global Non-animal Capsule Market: Others (2020-2025) & (K Units) Figure 23. Global Non-animal Capsule Sale Market Share by Application (2024) Figure 24. Global Non-animal Capsule Revenue Market Share by Application in 2025 Figure 25. Non-animal Capsule Sales by Company in 2025 (K Units) Figure 26. Global Non-animal Capsule Sales Market Share by Company in 2025 Figure 27. Non-animal Capsule Revenue by Company in 2025 ($ millions) Figure 28. Global Non-animal Capsule Revenue Market Share by Company in 2025 Figure 29. Global Non-animal Capsule Sales Market Share by Geographic Region (2020-2025) Figure 30. Global Non-animal Capsule Revenue Market Share by Geographic Region in 2025 Figure 31. Americas Non-animal Capsule Sales 2020-2025 (K Units) Figure 32. Americas Non-animal Capsule Revenue 2020-2025 ($ millions) Figure 33. APAC Non-animal Capsule Sales 2020-2025 (K Units) Figure 34. APAC Non-animal Capsule Revenue 2020-2025 ($ millions) Figure 35. Europe Non-animal Capsule Sales 2020-2025 (K Units) Figure 36. Europe Non-animal Capsule Revenue 2020-2025 ($ millions) Figure 37. Middle East & Africa Non-animal Capsule Sales 2020-2025 (K Units) Figure 38. Middle East & Africa Non-animal Capsule Revenue 2020-2025 ($ millions) Figure 39. Americas Non-animal Capsule Sales Market Share by Country in 2025 Figure 40. Americas Non-animal Capsule Revenue Market Share by Country (2020-2025) Figure 41. Americas Non-animal Capsule Sales Market Share by Type (2020-2025) Figure 42. Americas Non-animal Capsule Sales Market Share by Application (2020-2025) Figure 43. United States Non-animal Capsule Revenue Growth 2020-2025 ($ millions) Figure 44. Canada Non-animal Capsule Revenue Growth 2020-2025 ($ millions) Figure 45. Mexico Non-animal Capsule Revenue Growth 2020-2025 ($ millions) Figure 46. Brazil Non-animal Capsule Revenue Growth 2020-2025 ($ millions) Figure 47. APAC Non-animal Capsule Sales Market Share by Region in 2025 Figure 48. APAC Non-animal Capsule Revenue Market Share by Region (2020-2025) Figure 49. APAC Non-animal Capsule Sales Market Share by Type (2020-2025) Figure 50. APAC Non-animal Capsule Sales Market Share by Application (2020-2025) Figure 51. China Non-animal Capsule Revenue Growth 2020-2025 ($ millions) Figure 52. Japan Non-animal Capsule Revenue Growth 2020-2025 ($ millions) Figure 53. South Korea Non-animal Capsule Revenue Growth 2020-2025 ($ millions) Figure 54. Southeast Asia Non-animal Capsule Revenue Growth 2020-2025 ($ millions) Figure 55. India Non-animal Capsule Revenue Growth 2020-2025 ($ millions) Figure 56. Australia Non-animal Capsule Revenue Growth 2020-2025 ($ millions) Figure 57. China Taiwan Non-animal Capsule Revenue Growth 2020-2025 ($ millions) Figure 58. Europe Non-animal Capsule Sales Market Share by Country in 2025 Figure 59. Europe Non-animal Capsule Revenue Market Share by Country (2020-2025) Figure 60. Europe Non-animal Capsule Sales Market Share by Type (2020-2025) Figure 61. Europe Non-animal Capsule Sales Market Share by Application (2020-2025) Figure 62. Germany Non-animal Capsule Revenue Growth 2020-2025 ($ millions) Figure 63. France Non-animal Capsule Revenue Growth 2020-2025 ($ millions) Figure 64. UK Non-animal Capsule Revenue Growth 2020-2025 ($ millions) Figure 65. Italy Non-animal Capsule Revenue Growth 2020-2025 ($ millions) Figure 66. Russia Non-animal Capsule Revenue Growth 2020-2025 ($ millions) Figure 67. Middle East & Africa Non-animal Capsule Sales Market Share by Country (2020-2025) Figure 68. Middle East & Africa Non-animal Capsule Sales Market Share by Type (2020-2025) Figure 69. Middle East & Africa Non-animal Capsule Sales Market Share by Application (2020-2025) Figure 70. Egypt Non-animal Capsule Revenue Growth 2020-2025 ($ millions) Figure 71. South Africa Non-animal Capsule Revenue Growth 2020-2025 ($ millions) Figure 72. Israel Non-animal Capsule Revenue Growth 2020-2025 ($ millions) Figure 73. Turkey Non-animal Capsule Revenue Growth 2020-2025 ($ millions) Figure 74. GCC Countries Non-animal Capsule Revenue Growth 2020-2025 ($ millions) Figure 75. Manufacturing Cost Structure Analysis of Non-animal Capsule in 2025 Figure 76. Manufacturing Process Analysis of Non-animal Capsule Figure 77. Industry Chain Structure of Non-animal Capsule Figure 78. Channels of Distribution Figure 79. Global Non-animal Capsule Sales Market Forecast by Region (2026-2031) Figure 80. Global Non-animal Capsule Revenue Market Share Forecast by Region (2026-2031) Figure 81. Global Non-animal Capsule Sales Market Share Forecast by Type (2026-2031) Figure 82. Global Non-animal Capsule Revenue Market Share Forecast by Type (2026-2031) Figure 83. Global Non-animal Capsule Sales Market Share Forecast by Application (2026-2031) Figure 84. Global Non-animal Capsule Revenue Market Share Forecast by Application (2026-2031)
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医薬)の最新刊レポート
LP Information社の 医薬品・ヘルスケア分野 での最新刊レポート
本レポートと同じKEY WORD(capsule)の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|